Healthcare provider profile · identity verified

James A Morse, MD

Allopathic & Osteopathic Physicians|Family Medicine · KNOXVILLE, TN · NPI 1942246988

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show James A Morse, MD received $18.87 in general payments during 2025 across 1 reported records.

Edwards Lifesciences Corporation accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$18.87

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Edwards Lifesciences Corporation	Unresolved — no canonical attribution shown	$18.87	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$18.87	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	390	111
Levothyroxine Sodium	Levothyroxine Sodium	343	98
Atorvastatin Calcium	Atorvastatin Calcium	319	89
Amlodipine Besylate	Amlodipine Besylate	266	72
Losartan Potassium	Losartan Potassium	230	69
Metformin Hcl	Metformin Hcl	216	67
Omeprazole	Omeprazole	192	56
Lisinopril	Lisinopril	185	48
Finasteride	Finasteride	174	54
Escitalopram Oxalate	Escitalopram Oxalate	159	49
Tamsulosin Hcl	Tamsulosin Hcl	143	44
Gabapentin	Gabapentin	140	39
Alprazolam	Alprazolam	137	36
Meloxicam	Meloxicam	137	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	136	29
Tramadol Hcl	Tramadol Hcl	125	24
Pantoprazole Sodium	Pantoprazole Sodium	124	39
Fluticasone Propionate	Fluticasone Propionate	120	40
Trazodone Hcl	Trazodone Hcl	120	37
Hydrochlorothiazide	Hydrochlorothiazide	118	32
Metoprolol Succinate	Metoprolol Succinate	113	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	107	28
Montelukast Sodium	Montelukast Sodium	107	33
Mounjaro	Tirzepatide	105	23
Zolpidem Tartrate	Zolpidem Tartrate	104	28
Sertraline Hcl	Sertraline Hcl	99	31
Eliquis	Apixaban	97	23
Simvastatin	Simvastatin	85	27
Carvedilol	Carvedilol	84	21
Pravastatin Sodium	Pravastatin Sodium	79	24
Citalopram Hbr	Citalopram Hydrobromide	77	20
Allopurinol	Allopurinol	72	20
Ezetimibe	Ezetimibe	72	21
Lorazepam	Lorazepam	72	16
Metoprolol Tartrate	Metoprolol Tartrate	72	23
Tizanidine Hcl	Tizanidine Hcl	72	19
Glimepiride	Glimepiride	67	24
Atenolol	Atenolol	65	17
Valsartan	Valsartan	64	18
Celecoxib	Celecoxib	56	13
Furosemide	Furosemide	55	20
Albuterol Sulfate Hfa	Albuterol Sulfate	54	20
Clopidogrel	Clopidogrel Bisulfate	54	16
Ozempic	Semaglutide	51	15
Lovastatin	Lovastatin	50	15
Benazepril Hcl	Benazepril Hcl	47	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	suppressed
Famotidine	Famotidine	44	suppressed
Duloxetine Hcl	Duloxetine Hcl	43	13
Jardiance	Empagliflozin	43	12
Olmesartan Medoxomil	Olmesartan Medoxomil	42	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	42	30
Bupropion Xl	Bupropion Hcl	40	14
Fenofibrate	Fenofibrate	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	12
Telmisartan	Telmisartan	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	12
Donepezil Hcl	Donepezil Hcl	35	11
Farxiga	Dapagliflozin Propanediol	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Potassium Chloride	Potassium Chloride	35	14
Xarelto	Rivaroxaban	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Azithromycin	Azithromycin	33	29
Metformin Hcl Er	Metformin Hcl	33	suppressed
Pregabalin	Pregabalin	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Nystatin	Nystatin	32	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	11
Methylprednisolone	Methylprednisolone	30	25
Clonazepam	Clonazepam	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Estradiol	Estradiol	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	15
Januvia	Sitagliptin Phosphate	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Belsomra	Suvorexant	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Baclofen	Baclofen	23	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Minoxidil	Minoxidil	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	13
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Oxcarbazepine	Oxcarbazepine	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Primidone	Primidone	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Temazepam	Temazepam	18	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	17	17
Fluconazole	Fluconazole	17	12
Sucralfate	Sucralfate	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Meclizine Hcl	Meclizine Hcl	15	suppressed
Prednisone	Prednisone	15	suppressed
Synjardy	Empagliflozin/Metformin Hcl	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	14	suppressed
Glipizide	Glipizide	14	suppressed
Metaxalone	Metaxalone	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$18.87 · 1 records	Edwards Lifesciences Corporation	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error